Kaelis has partnered with COPPTECH to create onboard products with an antimicrobial protection that claims to not only eliminate SARS-COV-2 but also protect from other infectious diseases, pathogenic microbes, bacteria, virus and fungi.
The technology has been extensively tested and validated by the professor of Environmental Healthcare within the School of Biological Sciences at the University of Southampton, with Dr Bill Keevil certifying its capacity to inhibit the growth and to eliminate Covid-19 virus.
Kaelis is exclusively introducing this patented technology to the travel industry. The technology has been tested and acts as a shield against pathogenic microorganisms, rupturing their membrane, affecting their internal processes and finally eliminating them.
The effectiveness of this technology relies on the biocidal properties of copper and zinc.
This patented technology will allow Kaelis to produce new solutions for the onboard sector. All products treated with this technology are non-toxic, eco-friendly and safe for use. Products such as pyjamas, blankets, pillows, socks, pouches, trays, jugs, ice buckets, masks for the crew, galley equipment and many others will act as a shield against disease-causing microbes, inhibiting the growth and eliminating virus, bacteria and fungi.
LATAM is already protecting its passengers by using blankets that have COPPTECH’s technology incorporated. The look and feel of these blankets are the same as if they did not have the technology. Kaelis CEO, Federico Heitz, states: “The most important thing now is to convince passengers that travelling is safe. Only by taking the necessary action to do this, we will be able to make this industry thrive again.”
